All companies › FCF

FCF · FIRST COMMONWEALTH FINANCIAL CORP /PA/

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells9
Research cases0
Last filing2026-09-04

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-04 — Reske James R · sold 70 @ $21.29 2026-09-04 — Reske James R · sold 100 @ $21.27 2026-09-04 — Reske James R · sold 80 @ $21.20 2026-09-04 — Reske James R · sold 112 @ $21.25 2026-09-04 — Reske James R · sold 340 @ $21.25 2026-09-04 — Reske James R · sold 170 @ $21.26 2026-09-04 — Reske James R · sold 120 @ $21.27 2026-09-04 — Reske James R · sold 160 @ $21.30 2026-09-04 — Reske James R · sold 90 @ $21.30
2026-09-042026-09-04

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Reske James R EVP/Chief Financial Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $FCF is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-04', 'insider_name': 'Reske James R', 'insider_title': 'EVP/Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 70.0, 'price': 21.285, 'value': 1489.95, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Reske James R', 'insider_title': 'EVP/Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 100.0, 'price': 21.265, 'value': 2126.5, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Reske James R', 'insider_title': 'EVP/Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 80.0, 'price': 21.2, 'value': 1696.0, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Reske James R', 'insider_title': 'EVP/Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 112.0, 'price': 21.245, 'value': 2379.44, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Reske James R', 'insider_title': 'EVP/Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 340.0, 'price': 21.255, 'value': 7226.7, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Reske James R', 'insider_title': 'EVP/Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 170.0, 'price': 21.26, 'value': 3614.2, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Reske James R', 'insider_title': 'EVP/Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 120.0, 'price': 21.275, 'value': 2553.0, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Reske James R', 'insider_title': 'EVP/Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 160.0, 'price': 21.3, 'value': 3408.0, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Reske James R', 'insider_title': 'EVP/Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 90.0, 'price': 21.305, 'value': 1917.45, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for FCF today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.